Order number: 35N6.1
Part number: AC100007253
Produced for stability across temperature-sensitive applications, the HPLC column NUCLEODUR® C 8 ec offers an ideal solution for routine analyses involving aldehydes, basic, neutral, or acidic drugs, derivatized amino acids, fat-soluble vitamins, ketones, pesticides, and phenolic compounds. Featuring medium density monomeric octyl (C 8, MOS) modification, this reversed-phase column delivers excellent performance under pressure up to 600 bar and maintains its integrity at temperatures as high as 60°C. With a specific surface area of 340 m²/g and a particle size of 5 μm, it ensures efficient separations while providing a large capacity for sample loading. The column's endcapping further reduces the risk of unwanted interactions, making it suitable for various eluents
| Name | Value | |
|---|---|---|
| Phase | : | C 8 ec |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L7 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-9,0 |
| Column volume | : | 1.65 ml |
| Particle size | : | 5 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 8 NUCLEOSIL ® C 8 ec Spherisorb ® C 8 Symmetry ® C 8 Hypersil™ MOS Kromasil ® C 8 LiChrospher ® RP 8 |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Medium density monomeric octyl (C 8 , MOS) modification |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 100 x 4.6 mm |
| Recommended application(s) | : | Routine analyses Aldehydes Basic, neutral or acidic drugs Derivatised amino acids Fat-soluble vitamins Ketones Pesticides Phenolic compounds |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals interactions), some residual silanol interactions |
© 2026 Copyright. All Rights Reserved.
© 2026 Copyright. All Rights Reserved.